Cargando…
Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension
BACKGROUND: Pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) are debilitating diseases with a high mortality. Despite emerging treatments, pulmonary vascular resistance frequently remains elevated. However, the ketone body 3‐hydroxybutyrate (3‐OHB) may r...
Autores principales: | Nielsen, Roni, Christensen, Kristian Hylleberg, Gopalasingam, Nigopan, Berg‐Hansen, Kristoffer, Seefeldt, Jacob, Homilius, Casper, Boedtkjer, Ebbe, Andersen, Mads Jønsson, Wiggers, Henrik, Møller, Niels, Bøtker, Hans Erik, Mellemkjær, Søren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227291/ https://www.ncbi.nlm.nih.gov/pubmed/37183871 http://dx.doi.org/10.1161/JAHA.122.028232 |
Ejemplares similares
-
Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3‐Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects
por: Gopalasingam, Nigopan, et al.
Publicado: (2023) -
Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
por: Homilius, Casper, et al.
Publicado: (2023) -
Upregulated Na(+)/H(+)-Exchange Protects Human Colon Cancer Tissue against Intracellular Acidification
por: Voss, Ninna C. S., et al.
Publicado: (2019) -
PTPRG is an ischemia risk locus essential for HCO(3)(–)-dependent regulation of endothelial function and tissue perfusion
por: Hansen, Kristoffer B, et al.
Publicado: (2020) -
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
por: Nielsen, Roni, et al.
Publicado: (2019)